240 related articles for article (PubMed ID: 7867580)
61. Differential solubilization of placental lactogen (PL)- and growth hormone-binding sites: further evidence for a unique PL receptor in fetal and maternal liver.
Freemark M; Comer M; Korner G
Endocrinology; 1988 Jun; 122(6):2771-9. PubMed ID: 3371262
[TBL] [Abstract][Full Text] [Related]
62. The stimulatory effect of growth hormone, prolactin, and placental lactogen on beta-cell proliferation is not mediated by insulin-like growth factor-I.
Billestrup N; Nielsen JH
Endocrinology; 1991 Aug; 129(2):883-8. PubMed ID: 1677331
[TBL] [Abstract][Full Text] [Related]
63. Plasma growth hormone (GH)-binding proteins: effect on GH binding to receptors and GH action.
Mannor DA; Winer LM; Shaw MA; Baumann G
J Clin Endocrinol Metab; 1991 Jul; 73(1):30-4. PubMed ID: 2045472
[TBL] [Abstract][Full Text] [Related]
64. Dynamic character of human growth hormone and its receptor: normal mode analysis.
Kurihara Y; Watanabe T; Nojima H; Takeda-Shitaka M; Sumikawa H; Kamiya K; Umeyama H
Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):754-8. PubMed ID: 12843579
[TBL] [Abstract][Full Text] [Related]
65. Crystal structure and site 1 binding energetics of human placental lactogen.
Walsh ST; Kossiakoff AA
J Mol Biol; 2006 May; 358(3):773-84. PubMed ID: 16546209
[TBL] [Abstract][Full Text] [Related]
66. Systematic profiling of clinical missence mutation effects on the intermolecular interaction between human growth hormone and its receptor in isolated growth hormone deficiency.
Liu H; Xu L; Huang H; Zhao P; Yang R; Zhou Q; Liu G
J Mol Graph Model; 2019 Nov; 92():1-7. PubMed ID: 31279174
[TBL] [Abstract][Full Text] [Related]
67. Interaction of lactogenic hormones with the soluble extracellular domain of prolactin receptors.
Gertler A; Bignon C; Staten NR; Sakal E; Tchelet A; Krivi GG; Djiane J
Proc Soc Exp Biol Med; 1994 Jul; 206(3):273-9. PubMed ID: 8016164
[TBL] [Abstract][Full Text] [Related]
68. Performance, clinical chemistry, and carcass responses of finishing lambs to recombinant bovine somatotropin and bovine placental lactogen.
McLaughlin CL; Byatt JC; Hedrick HB; Veenhuizen JJ; Curran DF; Hintz RL; Hartnell GF; Kasser TR; Collier RJ; Baile CA
J Anim Sci; 1993 Dec; 71(12):3307-18. PubMed ID: 8294282
[TBL] [Abstract][Full Text] [Related]
69. Growth hormone binding protein in the rat: effects of gonadal steroids.
Carmignac DF; Gabrielsson BG; Robinson IC
Endocrinology; 1993 Dec; 133(6):2445-52. PubMed ID: 8243263
[TBL] [Abstract][Full Text] [Related]
70. Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes.
Ilondo MM; Damholt AB; Cunningham BA; Wells JA; De Meyts P; Shymko RM
Endocrinology; 1994 Jun; 134(6):2397-403. PubMed ID: 8194466
[TBL] [Abstract][Full Text] [Related]
71. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats.
Domené H; Krishnamurthi K; Eshet R; Gilad I; Laron Z; Koch I; Stannard B; Cassorla F; Roberts CT; LeRoith D
Endocrinology; 1993 Aug; 133(2):675-82. PubMed ID: 7688291
[TBL] [Abstract][Full Text] [Related]
72. Comparison of the effects of hypertonic sucrose and intracellular potassium depletion on growth hormone receptor binding kinetics and down-regulation in IM-9 cells: evidence for a sequential block of receptor--mediated endocytosis.
Ilondo MM; Smal J; de Meyts P; Courtoy PJ
Endocrinology; 1991 Mar; 128(3):1597-602. PubMed ID: 1999174
[TBL] [Abstract][Full Text] [Related]
73. Rat insulinoma cells express both a 115-kDa growth hormone receptor and a 95-kDa prolactin receptor structurally related to the hepatic receptors.
Møldrup A; Billestrup N; Nielsen JH
J Biol Chem; 1990 May; 265(15):8686-90. PubMed ID: 1692834
[TBL] [Abstract][Full Text] [Related]
74. The human growth hormone receptor of cultured human lymphocytes. Structural characteristics and glycosylation properties.
Asakawa K; Hedo JA; McElduff A; Rouiller DG; Waters MJ; Gorden P
Biochem J; 1986 Sep; 238(2):379-86. PubMed ID: 3099769
[TBL] [Abstract][Full Text] [Related]
75. Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities.
Bustamante JJ; Grigorian AL; Muñoz J; Aguilar RM; Treviño LR; Martinez AO; Haro LS
Growth Horm IGF Res; 2010 Aug; 20(4):298-304. PubMed ID: 20472479
[TBL] [Abstract][Full Text] [Related]
76. Polypeptide hormone receptor phosphorylation: is there a role in receptor-mediated endocytosis of human growth hormone?
Asakawa K; Grunberger G; McElduff A; Gorden P
Endocrinology; 1985 Aug; 117(2):631-7. PubMed ID: 2990856
[TBL] [Abstract][Full Text] [Related]
77. Receptor binding properties and insulin-like effects of human growth hormone and its 20 kDa-variant in rat adipocytes.
Smal J; Closset J; Hennen G; De Meyts P
J Biol Chem; 1987 Aug; 262(23):11071-9. PubMed ID: 3301849
[TBL] [Abstract][Full Text] [Related]
78. Binding inhibition by monoclonal antibodies of ovine placental lactogen to growth hormone receptors in human liver.
Chan JS; Nie ZR; Seidah NG; Chrétien M
FEBS Lett; 1986 May; 201(1):168-72. PubMed ID: 3011504
[TBL] [Abstract][Full Text] [Related]
79. Water-soluble specific growth hormone binding sites from cultured human lymphocytes: preparation and partial characterization.
McGuffin WL; Gavin JR; Lesniak MA; Gorden P; Roth J
Endocrinology; 1976 Jun; 98(6):1401-7. PubMed ID: 179794
[TBL] [Abstract][Full Text] [Related]
80. In vitro and in vivo studies of antagonistic effects of human growth hormone analogs.
Chen WY; Chen NY; Yun J; Wagner TE; Kopchick JJ
J Biol Chem; 1994 Jun; 269(22):15892-7. PubMed ID: 8195244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
